A recent study aimed to determine whether the combination of pregnancy-associated endothelial cell-specific molecule 1 (ESM-1), the placental growth factor (PLGF) in the first- and second-trimester maternal serum, and the uterine artery Doppler pulsatility index in the second trimester can predict preeclampsia. This evidence concerns the gene ESM1 and preeclampsia.